Sectors
NNNN
Anbio Biotechnology Class A Ordinary Shares
8.48
1 x 7.96
1 x 9.76
bid
ask
-
0.26
2.92%
1200 @ 04:00 PM
8.83 +0.35 (4.07%)
| Ytd | -71.78% | |
| 1y | -83.33% |
7.08
day range
13.80
7.08
52 week range
54.50
| Open | 10.10 | Prev Close | 8.74 | Low | 7.08 | High | 13.80 | Mkt Cap | 372.42M |
| Vol | 1.29M | Avg Vol | 42.96K | EPS | 0.07 | P/E | 122.62 | Forward P/E | N/A |
| Beta | 5.40 | Short Ratio | 1.79 | Inst. Own | 4.90% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 04-28 | 50-d Avg | 12.65 | 200-d Avg | 23.42 | 1yr Est | 0.00 |
| Income Statement | |||
| Weighted Average Shares | 43.67M | ||
| Balance Sheet | |||
| Cash and Equivalents | 7.77M | ||
| Cash and Equivalents (USD) | 7.77M | ||
| Investments | 4.13M | ||
| Investments Current | 4.13M | ||
| Trade and Non-Trade Receivables | 3.66M | ||
| Current Assets | 30.24M | ||
| Total Assets | 30.24M | ||
| Current Liabilities | 87.84K | ||
| Total Liabilities | 87.84K | ||
| Accumulated Retained Earnings (Deficit) | 23.58M | ||
| Shareholders Equity | 30.16M | ||
| Shareholders Equity (USD) | 30.16M | ||